Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

MLA

Alexandra Septfons, et al. Impact of Original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 Lineages on Vaccine Effectiveness of Two Doses of COVID-19 MRNA Vaccines: Results from a Nationwide Case-Control Study in France. July 2021. EBSCOhost, https://doi.org/10.1016/j.lanepe.2021.100171⟩.

APA

Alexandra Septfons, Simon Galmiche, Daniel Lévy-Bruhl, Simon Cauchemez, Sylvie van der Werf, Rebecca Grant, Alexandra Rogoff, Alexandra Maurizot, Cassandre Von Platen, Laura Schaeffer, Faïza Omar, Vincent Enouf, Olivia Chény, Christophe David, Alexandra Mailles, Fabrice Carrat, Bruno Lina, Louise H Lefrancois, Tiffany Charmet, … Alexandre Gaymard. (2021). Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. https://doi.org/10.1016/j.lanepe.2021.100171⟩

Chicago

Alexandra Septfons, Simon Galmiche, Daniel Lévy-Bruhl, Simon Cauchemez, Sylvie van der Werf, Rebecca Grant, Alexandra Rogoff, et al. 2021. “Impact of Original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 Lineages on Vaccine Effectiveness of Two Doses of COVID-19 MRNA Vaccines: Results from a Nationwide Case-Control Study in France,” July. doi:10.1016/j.lanepe.2021.100171⟩.